Mackenzie Financial’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-612
Closed -$9.5K 1692
2024
Q2
$9.5K Sell
612
-1,307
-68% -$31.1K ﹤0.01% 1528
2024
Q1
$62.3K Buy
1,919
+1,307
+214% +$55K ﹤0.01% 1467
2023
Q4
$35.2K Hold
612
﹤0.01% 1467
2023
Q3
$41.3K Hold
612
﹤0.01% 1423
2023
Q2
$51.4K Hold
612
﹤0.01% 1458
2023
Q1
$25.9K Hold
612
﹤0.01% 1476
2022
Q4
$28.1K Hold
612
﹤0.01% 1385
2022
Q3
$70K Sell
612
-33
-5% -$5.46K ﹤0.01% 1338
2022
Q2
$142K Buy
645
+186
+41% +$36.8K ﹤0.01% 1320
2022
Q1
$86K Buy
459
+153
+50% +$25.2K ﹤0.01% 1346
2021
Q4
$54K Sell
306
-18
-6% -$3.21K ﹤0.01% 1395
2021
Q3
$73K Sell
324
-15
-4% -$4.06K ﹤0.01% 1392
2021
Q2
$129K Buy
+339
New +$105K ﹤0.01% 1191

Other funds holding CTEV

Mackenzie Financial's CTEV Position: Q3 2024 in Review

Mackenzie Financial sold out of Claritev Corp (CTEV) in Q3 2024, closing a stake of 612 shares — an estimated $9.5K sold.

Mackenzie Financial first reported a position in CTEV in Q2 2021 and held it in 13 quarters. The position peaked at $142K in Q2 2022. 60 funds tracked by Wall St. Rank hold CTEV as of Q3 2024.

  • Mackenzie Financial reported no remaining Claritev Corp position as of Q3 2024 after selling out during the quarter.
  • Mackenzie Financial sold 612 Claritev Corp shares in Q3 2024, an estimated $9.5K.
  • Mackenzie Financial first reported a position in Claritev Corp in Q2 2021 and held it in 13 quarters.
  • Mackenzie Financial's Claritev Corp position peaked at $142K in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Claritev Corp as of Q3 2024.

Based on Mackenzie Financial's 13F filing for Q3 2024, filed 13 Nov 2024.